Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tamilnadu Petroproducts Limited (TNPETRO.NS)
Chennai, IN
Tamilnadu Petroproducts Limited, established in 1984 and headquartered in Chennai, India, specializes in the production and distribution of a range of petrochemical and industrial intermediate chemical products. Operating both domestically and internationally, the company offers a diverse portfolio of chemicals. Its flagship product, SUPERLAB brand linear alkyl benzene (LAB), is an organic compound extensively utilized in the formulation of household, institutional, and industrial cleaning agents. TPL also provides caustic soda, a fundamental chemical serving the textile, pulp and paper, aluminum, and soap and detergent industries. Chlorine, a by-product of caustic soda manufacturing, finds applications in numerous sectors including vinyl chloride, chlorinated paraffin wax, pulp and paper production, and water purification. Additionally, the company supplies hydrogen and various chlorine derivatives such as hydrochloric acid, sodium hypochlorite, and ammonium chloride. Completing its product line is propylene oxide, a colorless, volatile, and flammable organic liquid compound essential for the automotive, domestic appliance, and industrial insulation industries.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.31% | +2.19% | +2.26% | -1.23% | -13.81% | -14.81% | +11.12% | +15.61% | -4.86% | +325.53% | +70.62% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-19.7% Q1'26: -72.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+66.9% ★ Q1'26: -69.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-12.8% Q1'26: -213.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.2% Q1'26: +3.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+7.0% ★ Q1'26: +1.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.55× Q1'26: 10.17× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 1996 actual |
Mar 1997 actual |
Mar 1998 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
|---|---|---|---|---|---|---|
| Revenue |
3.90B
est.
|
3.87B
est.
|
4.43B
est.
|
10.49B
est: 10.79B (-2.8%)
|
12.45B
est: 19.04B (-34.6%)
|
12.23B
est: 34.10B (-64.1%)
|
| EBITDA |
381.25M
est.
|
692.57M
est.
|
424.65M
est.
|
926.69M
est: 1.03B (-10.4%)
|
918.09M
est: 1.81B (-49.1%)
|
1.08B
est: 3.35B (-67.9%)
|
| EBIT |
326.41M
est.
|
847.00M
est.
|
363.57M
est.
|
836.42M
est: 885.74M (-5.6%)
|
795.33M
est: 1.43B (-44.3%)
|
861.46M
est: 2.87B (-70.0%)
|
| Net Income |
737.55M
est.
|
647.64M
est.
|
173.39M
est.
|
483.19M
est: 407.00M (+18.7%)
|
570.32M
est: 954.80M (-40.3%)
|
632.81M
est: 794.31M (-20.3%)
|
| SGA |
87.87M
est.
|
87.15M
est.
|
99.84M
est.
|
313.45M
est: 243.23M (+28.9%)
|
337.91M
est: 6.07B (-94.4%)
|
390.04M
est: 772.47M (-49.5%)
|
| EPS |
8.20
est.
|
4.21
est.
|
1.94
est.
|
5.37
est: 4.55 (+18.0%)
|
6.34
est: 6.26 (+1.3%)
|
7.03
est: 8.79 (-20.0%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| D. Senthi Kumar | MD & Whole-Time Director | 9M | male |
| C. Parthiban | Chief Financial Officer | — | male |
| K. Vasantha Kumar | Deputy General Manager of Human Resources | — | male |
| N. Murugan | Vice President of Operations | — | male |
| S. Sridharan | Assistant Vice President of Marketing | — | male |
| Sangeetha Sekar | Company Secretary & Compliance Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TNPETRO.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
